ZIMUNESQ
RegisteredWord Mark
•
Ownership
GS
Owner Name
Type: Organization / Corporation
Address
IDA Business and Technology Park,, Carrigtohill Co. Cork T45 DP77
IE
Critical Dates
First Use Date
Not filed yet
Filing Date
Feb 20, 2025
Registration Date
Feb 10, 2026
Mark Descriptions
Goods
Class 5
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders...
Mark Elements
Text Mark
ZIMUNESQ
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 05:52 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
ZIMUNESQ is a standard character mark for pharmaceutical preparations in class 005, including antivirals, anti-infectives, anti-fibrotics, and treatments for HIV, liver diseases, hematological disorders, oncology, inflammation, autoimmune conditions, respiratory and pulmonary issues, kidney diseases, arthritis, and gastrointestinal disorders, plus classes 006, 018, 044, 046, 051, and 052. The mark is owned by Gilead Sciences Ireland UC, an Irish corporation. It is currently registered on the Principal Register (Reg. No. 8131793) as of February 10, 2026, with an expiration date of February 20, 2035, based on international registration WO1850824 under Section 66A with priority from September 24, 2024. No active oppositions or legal proceedings are present.
Recent Activity
The application (Ser. No. 79422126), based on international registration dated February 20, 2025 and notified domestically on April 24, 2025, received a non-final office action on September 9, 2025, which was overcome by a TEAS response on November 4, 2025. It was approved for publication on November 26, 2025, published for opposition on December 23, 2025, and registered on February 10, 2026.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach